Menu
GWAS Study

A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer's disease.

Wightman DP, Jansen IE, Savage JE et al.

34493870 PubMed ID
GWAS Study Type
1126563 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

WD
Wightman DP
JI
Jansen IE
SJ
Savage JE
SA
Shadrin AA
BS
Bahrami S
HD
Holland D
RA
Rongve A
BS
Børte S
WB
Winsvold BS
DO
Drange OK
MA
Martinsen AE
SA
Skogholt AH
WC
Willer C
BG
Bråthen G
BI
Bosnes I
NJ
Nielsen JB
FL
Fritsche LG
TL
Thomas LF
PL
Pedersen LM
GM
Gabrielsen ME
JM
Johnsen MB
MT
Meisingset TW
ZW
Zhou W
PP
Proitsi P
HA
Hodges A
DR
Dobson R
VL
Velayudhan L
HK
Heilbron K
AA
Auton A
SJ
Sealock JM
DL
Davis LK
PN
Pedersen NL
RC
Reynolds CA
KI
Karlsson IK
MS
Magnusson S
SH
Stefansson H
TS
Thordardottir S
JP
Jonsson PV
SJ
Snaedal J
ZA
Zettergren A
SI
Skoog I
KS
Kern S
WM
Waern M
ZH
Zetterberg H
BK
Blennow K
SE
Stordal E
HK
Hveem K
ZJ
Zwart JA
AL
Athanasiu L
SP
Selnes P
SI
Saltvedt I
SS
Sando SB
UI
Ulstein I
DS
Djurovic S
FT
Fladby T
AD
Aarsland D
SG
Selbæk G
RS
Ripke S
SK
Stefansson K
AO
Andreassen OA
PD
Posthuma D
Chapter II

Abstract

Summary of the research findings

Late-onset Alzheimer's disease is a prevalent age-related polygenic disease that accounts for 50-70% of dementia cases. Currently, only a fraction of the genetic variants underlying Alzheimer's disease have been identified. Here we show that increased sample sizes allowed identification of seven previously unidentified genetic loci contributing to Alzheimer's disease. This study highlights microglia, immune cells and protein catabolism as relevant to late-onset Alzheimer's disease, while identifying and prioritizing previously unidentified genes of potential interest. We anticipate that these results can be included in larger meta-analyses of Alzheimer's disease to identify further genetic variants that contribute to Alzheimer's pathology.

43,725 European ancestry cases, 46,613 European ancestry proxy cases, 1,036,225 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

1126563
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
Finland, Iceland, Norway, Spain, Sweden, U.K., U.S.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.